-
1
-
-
64049088667
-
Hepatitis C infection and chronic renal diseases
-
. doi: 10. 2215/CJN. 03710708
-
Perico N, Cattaneo D, Bikbov B, Remuzzi G. Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol. 2009;4(1):207-220. doi: 10. 2215/CJN. 03710708.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, Issue.1
, pp. 207-220
-
-
Perico, N.1
Cattaneo, D.2
Bikbov, B.3
Remuzzi, G.4
-
2
-
-
34748874598
-
The kidney transplant recipient with hepatitis C infection: Pre-and posttransplantation treatment
-
Terrault NA, Adey DB. The kidney transplant recipient with hepatitis C infection: pre-and posttransplantation treatment. Clin J Am Soc Nephrol. 2007;2(3):563-575.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, Issue.3
, pp. 563-575
-
-
Terrault, N.A.1
Adey, D.B.2
-
3
-
-
3042771789
-
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection
-
Zekry A, Gleeson M, Guney S, McCaughan GW. A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection. Liver Transpl. 2004;10(1):52-57.
-
(2004)
Liver Transpl
, vol.10
, Issue.1
, pp. 52-57
-
-
Zekry, A.1
Gleeson, M.2
Guney, S.3
McCaughan, G.W.4
-
4
-
-
0034728055
-
Sirolimus-tacrolimus combination immuno-suppression
-
McAlister VC, Gao Z, Peltekian K, Domingues J, Mahalati K, MacDonald AS. Sirolimus-tacrolimus combination immuno-suppression. Lancet. 2000;355(9201):376-377.
-
(2000)
Lancet
, vol.355
, Issue.9201
, pp. 376-377
-
-
McAlister, V.C.1
Gao, Z.2
Peltekian, K.3
Domingues, J.4
Mahalati, K.5
Macdonald, A.S.6
-
5
-
-
60749126501
-
KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease
-
Kidney Disease: Improving Global Outcomes (KDIGO), doi: 10. 1038/ki. 2008. 81
-
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl. 2008;(109):S1-S99. doi: 10. 1038/ki. 2008. 81.
-
(2008)
Kidney Int Suppl
, Issue.109
-
-
-
6
-
-
60749088323
-
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: A European Renal Best Practice (ERBP) position statement
-
doi: 10. 1093/ndt/gfn608
-
Covic A, Abramowicz D, Bruchfeld A, et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant. 2009;24(3):719-727. doi: 10. 1093/ndt/gfn608.
-
(2009)
Nephrol Dial Transplant
, vol.24
, Issue.3
, pp. 719-727
-
-
Covic, A.1
Abramowicz, D.2
Bruchfeld, A.3
-
7
-
-
0035401238
-
Hepatitis C virus infection and de novo glomerular lesions in renal allografts
-
Cruzado JM, Carrera M, Torras J, Grinyó JM. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant. 2001;1(2):171-178.
-
(2001)
Am J Transplant
, vol.1
, Issue.2
, pp. 171-178
-
-
Cruzado, J.M.1
Carrera, M.2
Torras, J.3
Grinyó, J.M.4
-
8
-
-
77949908335
-
First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation
-
doi: 10. 1097/TP. 0b013e3181c7dcc0
-
Di Benedetto F, Di Sandro S, De Ruvo N, et al. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation. 2010;89(6):733-738. doi: 10. 1097/TP. 0b013e3181c7dcc0.
-
(2010)
Transplantation
, vol.89
, Issue.6
, pp. 733-738
-
-
Di Benedetto, F.1
Di Sandro, S.2
De Ruvo, N.3
-
9
-
-
68949205629
-
Switching to sirolimus in renal transplant recipients with hepatitis C virus: A safe option
-
doi: 10. 1016/j. transproceed. 2009. 06. 064
-
Gallego R, Henriquez F, Oliva E, et al. Switching to sirolimus in renal transplant recipients with hepatitis C virus: a safe option. Transplant Proc. 2009;41(6):2334-2336. doi: 10. 1016/j. transproceed. 2009. 06. 064.
-
(2009)
Transplant Proc
, vol.41
, Issue.6
, pp. 2334-2336
-
-
Gallego, R.1
Henriquez, F.2
Oliva, E.3
-
10
-
-
27744608130
-
Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis
-
Samonakis DN, Cholongitas E, Triantos CK, et al. Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis. J Hepatol. 2005;43(6):1091-1093.
-
(2005)
J Hepatol
, vol.43
, Issue.6
, pp. 1091-1093
-
-
Samonakis, D.N.1
Cholongitas, E.2
Triantos, C.K.3
-
11
-
-
10344243982
-
Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation
-
Kornberg A, Küpper B, Tannapfel A, Hommann M, Scheele J. Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation. Int Immunopharmacol. 2005;5(1):107-115.
-
(2005)
Int Immunopharmacol
, vol.5
, Issue.1
, pp. 107-115
-
-
Kornberg, A.1
Küpper, B.2
Tannapfel, A.3
Hommann, M.4
Scheele, J.5
-
12
-
-
0035884399
-
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus
-
Sindhi R, Webber S, Venkataramanan R, et al. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation. 2001;72(5):851-855.
-
(2001)
Transplantation
, vol.72
, Issue.5
, pp. 851-855
-
-
Sindhi, R.1
Webber, S.2
Venkataramanan, R.3
-
13
-
-
0042090489
-
Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas
-
Nepomuceno RR, Balatoni CE, Natkunam Y, Snow AL, Krams SM, Martinez OM. Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. Cancer Res. 2003;63(15):4472-4480.
-
(2003)
Cancer Res
, vol.63
, Issue.15
, pp. 4472-4480
-
-
Nepomuceno, R.R.1
Balatoni, C.E.2
Natkunam, Y.3
Snow, A.L.4
Krams, S.M.5
Martinez, O.M.6
-
14
-
-
34447641669
-
Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: Model to predict HCV cirrhosis after liver transplantation
-
Iacob S, Cicinnati VR, Hilgard P, et al. Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. Transplantation. 2007;84(1):56-63.
-
(2007)
Transplantation
, vol.84
, Issue.1
, pp. 56-63
-
-
Iacob, S.1
Cicinnati, V.R.2
Hilgard, P.3
|